Moderna COO Juan Andres Files Initial Statement of Beneficial Ownership
Moderna, Inc.
Subscribe to track MRNA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
{"title": "Moderna, Inc. (MRNA) Initial Statement of Ownership (Form 3)", "color": 3447003, "fields": [{"name": "Insider", "value": "Juan Andres (Chief Operating Officer)", "inline": false}, {"name": "Direct Holdings", "value": "125,000 Common Stock", "inline": true}, {"name": "Filing Date", "value": "2026-10-05", "inline": true}]}
Comprehensive Analysis
Moderna, Inc. (MRNA) - Initial Statement of Beneficial Ownership (Form 3)
Insider: Juan Andres
Role: Chief Operating Officer
Event Date: October 5, 2026
Filing Date: October 5, 2026
Summary of Reported Holdings:
- Common Stock: 125,000 shares held directly.
- Derivative Holdings: None reported.
Key Takeaways:
- This Form 3 represents an initial statement of beneficial ownership for Juan Andres serving as Chief Operating Officer of Moderna, Inc.
- The insider reports a substantial starting position of 125,000 directly owned shares of Common Stock as of the reporting date.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.